1. Metformin potentiates the anticancer activities of gemcitabine and cisplatin against cholangiocarcinoma cells in vitro and in vivo
   Hua-Qiang Zhu et al, 2016 CrossRef
2. Crucial microRNAs and genes in metformin’s anti-pancreatic cancer effect explored by microRNA-mRNA integrated analysis
   Yilong Li et al, 2017, Invest New Drugs CrossRef
3. Diabetes mellitus and metformin in hepatocellular carcinoma
   Koji Fujita et al, 2016, WJG CrossRef
4. Metformin-suppressed differentiation of human visceral preadipocytes: Involvement of microRNAs
   Koji Fujita et al, 2016 CrossRef
5. Inhibitory effect of metformin combined with gemcitabine on pancreatic cancer cells in vitro and in vivo
   Yuqi Shi et al, 2016 CrossRef
6. Metformin Induces Growth Inhibition and Cell Cycle Arrest by Upregulating MicroRNA34a in Renal Cancer Cells
   Wei Xie et al, 2017, Med Sci Monit CrossRef
7. Expression of AXL receptor tyrosine kinase relates to monocyte dysfunction and severity of cirrhosis
   Robert Brenig et al, 2020, Life Sci. Alliance CrossRef
8. Anti-diabetic drug metformin inhibits cell proliferation and tumor growth in gallbladder cancer via G0/G1 cell cycle arrest
   Takuma Yamashita et al, 2020, Anti-Cancer Drugs CrossRef
9. Anticancer mechanisms of metformin: A review of the current evidence.
   Bin Zhao et al, 2020, Life Sci CrossRef
10. Metformin attenuates hypoxia‑induced resistance to cisplatin in the HepG2 cell line
    Hiromasa Fujita et al, 2018, Oncol Lett CrossRef
11. Metformin‑induced apoptosis facilitates degradation of the cellular caspase 8 (FLICE)‑like inhibitory protein through a caspase‑dependent pathway in human renal cell carcinoma A498 cells
    Ji‑Hoon Jang et al, 2018, Oncol Lett CrossRef
12. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis
    Xiaowen Huang et al, 2020, EBioMedicine CrossRef
13. Association of Diabetes Mellitus and Cholangiocarcinoma: Update of Evidence and the Effects of Antidiabetic Medication
    Charupong Saengboonmee et al, 2020, Canadian Journal of Diabetes CrossRef
14. Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells
    Sabina Di Matteo et al, 2021, Sci Rep CrossRef
15. How metformin affects various malignancies by means of microRNAs: a brief review
    Nahid Alimoradi et al, 2021, Cancer Cell Int CrossRef
16. Repurposing metformin for the treatment of gastrointestinal cancer
    Ademar Dantas Cunha Júnior et al, 2021, WJG CrossRef
17. Coexpression of EphA10 and Gli3 promotes breast cancer cell proliferation, invasion and migration
    Jing Peng et al, 2021, J Investig Med CrossRef
18. miR-10a-5p Inhibits the Differentiation of Goat Intramuscular Preadipocytes by Targeting KLF8 in Goats
    Qing Xu et al, 2021, Front. Mol. Biosci. CrossRef
19. null
    Yeliz Yılmaz et al, 2021 CrossRef
20. Metformin Use and Survival in Patients with Advanced Extrahepatic Cholangiocarcinoma: A Single-Center Cohort Study in Fuyang, China
    Jinqing Wu et al, 2021, Gastroenterology Research and Practice CrossRef
21. TAM Receptors in the Pathophysiology of Liver Disease
    Emilio Flint et al, 2022, Livers CrossRef
22. HNRNPA2/B1 is upregulated in endocrine-resistant LCC9 breast cancer cells and alters the miRNA transcriptome when overexpressed in MCF-7 cells
    Carolyn M. Klinge et al, 2019, Sci Rep CrossRef
23. Impact of metformin on the incidence of human cholangiocarcinoma in diabetic patients: a systematic review and meta-analysis
    Alice Laffusa et al, 2023 CrossRef
24. Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review
    Yi Zhang et al, 2023, Biomolecules CrossRef
25. Effects of Metformin on Risk and Prognosis of Biliary Tract Cancer: A Systematic Review and Meta-Analysis
    Junhong Chen et al, 2023, Medicina CrossRef
26. Influence of diabetes mellitus and effectiveness of metformin on hepatocellular carcinoma
    Masafumi Ono et al, 2023, Hepatology Research CrossRef
27. Bioenergetic alteration in gastrointestinal cancers: The good, the bad and the ugly
    Yu-De Chu et al, 2023, World J Gastroenterol CrossRef
28. Clinical efficacy of metformin in familial adenomatous polyposis and the effect of intestinal flora
    Linxin Zhou et al, 2024, Orphanet J Rare Dis CrossRef
29. Anexelekto (AXL) no more: microRNA-155 (miR-155) controls the “Uncontrolled” in SARS-CoV-2
    K. I. Papadopoulos et al, 2024, Human Cell CrossRef